Abstract:Expression of p21 has been shown to be up-regulated by the p53 tumor suppressor gene in vitro in response to DNA-damaging agents. However, p21 expression can be regulated independently of p53, and here we show that expression of p21 in various tissues during development and in the adult mouse occurs in the absence of p53 function. However, most tissues tested did require p53 for p21 induction following exposure of the whole animal to gamma irradiation. These results show that normal tissue expression of p21 to high levels is not dependent on p53 and confirm that induction of p21 by DNA-damaging agents does require p53. p21 is expressed upon differentiation of p53-deficient murine erythroleukemia (MEL) cells, and the kinetics of induction of p21 in this system suggest that it may be involved in the growth arrest that precedes terminal differentiation. The gene is up-regulated in mouse fibroblasts in response to serum restimulation but the kinetics and levels of induction differ between wild-type and mutant cells. Expression of p21 message following serum restimulation is superinducible by cycloheximide in wild-type but not in p53-deficient cells. The increases in p21 mRNA are reflected in changes in p21 protein levels. p21 expression also appears to be regulated at the post-transcriptional level because moderate increases in mRNA expression, during differentiation of MEL cells and upon serum restimulation of fibroblasts, are followed by large increases in protein levels. Regulation of the mouse p21 promoter by p53 depends on two critical p53-binding sites located 1.95 and 2.85 kb upstream from the transcriptional initiation site. The sequences mediating serum responsiveness of the promoter map to a region containing the proximal p53 site. p53 appears to play a critical role in p21 induction following DNA damage. Moreover, p21 can be regulated independently of p53 in several situations including during normal tissue development, following serum stimulation, and during cellular differentiation.

Radiation-induced cell cycle arrest compromised by p21 deficiency

P21 Delays Tumor Onset by Preservation of Chromosomal Stability

Mice Lacking P21 CIP1/WAF1 Undergo Normal Development, but Are Defective in G1 Checkpoint Control

p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.

p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation

P21 Disrupts the Interaction Between Cdk2 and the E2F-p130 Complex.

Mutagenesis in Vivo in T Cells of P21-Deficient Mice

Persistent P21 Expression after Nutlin-3a Removal is Associated with Senescence-Like Arrest in 4n Cells

P53 and P21(waf1) Are Recruited to Distinct PML-Containing Nuclear Foci in Irradiated and Nutlin-3a-Treated U2OS Cells

p21: A Two-Faced Genome Guardian

Involvement of P53 and P21 in Cellular Defects and Tumorigenesis in Atm−/− Mice

p21 in Cancer Research

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.

Involvement of P21 and P27 in the Regulation of CDK Activity and Cell Cycle Progression in the Regenerating Liver.

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53

Krüppel-like Factor 4 Mediates P53-Dependent G1/S Cell Cycle Arrest in Response to DNA Damage

Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities

The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo

Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts